We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The FDA has renewed and expanded its real-world cancer data collaboration with Flatiron Health for another two years, to continue its work into the validation of related clinical endpoints and development of real-world control arms....
Roche and Flatiron Health, Inc. announced that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health.